Document Detail


Antitumoral effects of squamocin on parental and multidrug resistant MCF7 (human breast adenocarcinoma) cell lines.
MedLine Citation:
PMID:  10462079     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The antiproliferative effects of squamocin, one of the easiest annonaceous acetogenins to obtain, were studied in the parental (MCF7-S) and the multidrug resistant (MCF7-R) human breast adenocarcinoma cell lines. Squamocin inhibited proliferation of both cell lines identically, by blocking the cell cycle in the G1-phase. This inhibition was reversible in the long term. Squamocin decreased the ATP pool in both MCF7 cell lines, but did not seem to induce apoptosis. Cytotoxic activity of adriamycin was not restored in MCF7-R Pgp expressing cells by squamocin addition.
Authors:
S Raynaud; F Némati; L Miccoli; P Michel; M F Poupon; C Fourneau; A Laurens; R Hocquemiller
Related Documents :
3108219 - Kinetic analysis of active efflux of vincristine from multidrug-resistant p388 leukemia...
8391919 - Localization of a novel multidrug resistance-associated gene in the ht1080/dr4 and h69a...
19291609 - 20s-protopanaxadiol inhibits p-glycoprotein in multidrug resistant cancer cells.
3875789 - Effect of reduced temperature on glycoprotein (ig, hla) processing and transport in lym...
1969329 - Transfer of adriamycin resistance by fusion of mr 170,000 p-glycoprotein to the plasma ...
8907249 - Reversal of doxorubicin resistance by the amiloride analogue eipa in multidrug resistan...
24221569 - Preprophase bands of microtubules and the cell cycle: kinetics and experimental uncoupl...
12792879 - Cisplatin induced gamma-glutamyltransferase up-regulation, hypertrophy and differentiat...
17599069 - Functional dynamics of h3k9 methylation during meiotic prophase progression.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Life sciences     Volume:  65     ISSN:  0024-3205     ISO Abbreviation:  Life Sci.     Publication Date:  1999  
Date Detail:
Created Date:  1999-09-08     Completed Date:  1999-09-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0375521     Medline TA:  Life Sci     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  525-33     Citation Subset:  IM    
Affiliation:
Laboratoire de Pharmacognosie, URA CNRS 1843 (BIOCIS), Faculté de Pharmacie, Université de Paris XI, Châtenay-Malabry, France. reynald.hocquemiller@cep.u-psud.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / drug therapy*,  pathology
Antibiotics, Antineoplastic / pharmacology,  therapeutic use
Antineoplastic Agents, Phytogenic / pharmacology*,  therapeutic use
Apoptosis / drug effects
Breast Neoplasms / drug therapy*,  pathology
Cell Division / drug effects
Dose-Response Relationship, Drug
Doxorubicin / pharmacology,  therapeutic use
Drug Resistance, Multiple
Female
Furans / pharmacology*,  therapeutic use
G1 Phase / drug effects
Humans
Lactones / pharmacology*,  therapeutic use
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 0/Antineoplastic Agents, Phytogenic; 0/Furans; 0/Lactones; 120298-30-8/squamocin; 23214-92-8/Doxorubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of SR-4987 stromal cells in the modulation of doxorubicin toxicity to in vitro granulocyte-macr...
Next Document:  p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of ha...